Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

YUFLYMA 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/YUFLYMA 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA

Approved

STANDARD

YUFLYMA 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA

Celltrion Healthcare Hungary Kft.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Mar 31, 2021
Approval ID: c1c63c1e809ffb63
Company: Celltrion Healthcare Hungary Kft.
Type: Standard

Approval Details

Approval Id: c1c63c1e809ffb63
Drug Cima Aemps Name: YUFLYMA 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA
Register Number: 1201513010
Holder Company Name: Celltrion Healthcare Hungary Kft.
Marketing Company Name: Kern Pharma S.L.
Holder Company Detail Path: /organization/celltrion-healthcare-hungary-kft
Marketing Company Detail Path: /organization/kern-pharma-s-l
Authorization Date: 2021-03-31
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 40 mg
Route Of Administration: VÍA SUBCUTÁNEA
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Celltrion Healthcare Hungary Kft.
Company Detail Path: /organization/celltrion-healthcare-hungary-kft

Company Information

Pharmaceutical Company Name: Celltrion Healthcare Hungary Kft
Country Name: Hungary

Active Ingredients

ADALIMUMAB

40 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 31, 2021

Approval ID

c1c63c1e809ffb63

Type

Standard

Back to CIMA-AEMPS Approvals